HMP Global January 3, 2025
Jo Varshney, DVM, PhD, founder and CEO of VeriSIM Life
In this interview, Dr Jo Varshney, founder and CEO of VeriSIM Life, discusses the complexities of drug development, the role of AI in accelerating discovery, the integration of real-world evidence, and strategies to reduce costs while advancing innovation.
Please state your name, title, and any relevant professional experience.
Jo Varshney, DVM, PhD: Hello, I’m Dr Jo Varshney. I am the founder and CEO of VeriSIM Life and our pharmaceutical subsidiary, PulmoSIM Therapeutics. I am a veterinarian with a PhD in comparative oncology/genomics, and I serve on several advisory boards, including the Critical Path Institute.
What are the key stages of drug development, and how do they influence the likelihood...
Today's Sponsors
Today's Sponsor